Lizhu Group: Injection of Alprazolam Microspheres approved for registration.

Announcement from LIZHU Group: its wholly-owned subsidiary, Zhuhai LIZHU Microsphere Technology Co., Ltd., has received the "Drug Registration Certificate" issued by the National Medical Products Administration, approving the market launch of the injectable Paliperidone microspheres. The injectable Paliperidone microspheres are a long-acting sustained-release formulation developed independently by LIZHU Microsphere, indicated for adult schizophrenia. As of the announcement date, the accumulated direct investment in research and development is approximately 78.8875 million yuan. Paliperidone long-acting microsphere formulation is only produced by LIZHU Microspheres, and there are no other Paliperidone microsphere products on the market worldwide.